Paravasthu Mukund's Form 4 filing
NovoCure LtdNVCR · filed Nov 12, 2026
- Accession no.
- 0002039078-26-000007
- Filed
- Nov 12, 2026, 4:07 PM ET
- Trade date
- Nov 9, 2026
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $39.6K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Paravasthu MukundCIK 0002039078 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | Ordinary Shares | SSaleDisposed | −3,079 | $12.86F2 | −$39,602.1 | 69,753 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $12.61 USD to $13.11 USD; the price reported above reflects the weighted average sale price.
Referenced by the price of 1 transaction in Table I.